For Immediate Release - September 13, 2012

GOVERNOR PATRICK VISITS ABIOMED, HIGHLIGHTS INNOVATION AND RESEARCH AS KEY PARTS OF MASSACHUSETTS’ WORLD-LEADING LIFE SCIENCES INDUSTRY

Abiomed Visit
Governor Patrick and Abiomed CEO Michael Minogue observe the original artificial heart prototype during the Governor's visit to Abiomed. (Photo Credit: Eric Hayes / Governor's Office) View additional photos.

DANVERS – Thursday, September 13, 2012 – Governor Deval Patrick today visited Abiomed, a Danvers life sciences company that creates instruments designed to help the pumping function of the heart, to promote the innovation and research programs that have made Massachusetts a world leader in the life sciences industry.

“With a growing industry of companies that are committed to innovation and making us healthier, Massachusetts has become a world leader in life sciences,” said Governor Patrick. “Abiomed’s pioneering work in heart technology is indicative of the kind of advancements Massachusetts companies are making on behalf of patients and doctors around the world.”

“Abiomed is proud to host Governor Deval Patrick and appreciates his continued support to the medical device industry,” said Michael R. Minogue, Chairman, President and Chief Executive Officer of Abiomed. “Massachusetts, by design, is home to some of the leading hospitals, universities and medical device companies in the world. We must continue to collaborate in order to create policies that help small businesses and to sustain an environment that supports innovation for patients and cost-effective care.”

Governor Patrick strengthened Massachusetts’ global leadership in life sciences in 2008 by signing a 10-year, $1 billion life sciences investment package. Over the last four years, the Commonwealth has invested more than $300 million in the industry, leveraging more than $938 million in third-party investments and creating thousands of jobs in both construction and in the life sciences.

The Life Sciences Initiative melds all of the state’s key resources in order to spur research, investment, innovation and commercialization. Now the life sciences industry in Massachusetts is thriving, with more than 52 percent job growth in the biopharma sector since 2001 and more than 80,000 employees working in the life sciences.

In June, Massachusetts hosted the BIO International Convention, which brought more than 15,000 participants and 3,000 companies to Boston. BIO gave Governor Patrick, Lieutenant Governor Timothy Murray, state and industry leaders an opportunity to showcase Massachusetts as a global leader in the life sciences industry, and the preeminent place for life sciences companies to invest in and expand. During the convention, Governor Patrick announced innovation partnerships with regions in Spain, and Denmark and Sweden, and the creation of a neuroscience consortium formed by seven companies.

Founded in 1981, Abiomed employs more than 400 people and maintains its corporate headquarters in Danvers with a European division in Aachen, Germany. The company focuses on developing new technologies designed to assist or replace the life-sustaining pumping function of the heart. Abiomed developed the first total replacement heart and the world’s smallest heart pump.

“Under the leadership of Governor Patrick, Massachusetts has firmly established its role as an international leader in life sciences,” said Senator Gale Candaras, Senate Chair of the Joint Committee on Economic Development and Emerging Technologies. “The Governor and the Legislature are dedicated to fostering the kind of innovative scientific work that advances technology and creates jobs within the Commonwealth. The success of Abiomed in Massachusetts is a model for other companies looking to call Massachusetts home.”

“I am so pleased the Governor is visiting Abiomed today,” said State Representative Ted Speliotis. “Abiomed is a world leader in innovation and they are one of several companies on the North Shore working to provide us with a longer and healthier life. No work is more important.”

“Thank you to the Patrick-Murray Administration’s commitment to the Life Sciences Initiative. With their support, companies like Abiomed are welcome to thrive in Massachusetts,” said Senator Frederick Berry.

###

Follow us on Twitter – View our Photos – Watch our Videos